India covid-19 patient Coronavirus India

WHO-led trial to study 3 anti-inflammatory drugs as potential treatments for Covid patients

Reading now: 449
www.livemint.com

coronavirus patients. "These therapies - artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised Covid-19 patients," the WHO said in a statement.

Artesunate is already used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn's Disease and rheumatoid arthritis.

Meanwhile, the highly-transmissible Delta variant of Covid-19 has now been reported in 135 countries, as per the WHO, which said the cumulative number of coronavirus cases reported globally could exceed 200 million by next week.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA